The epilepsy market size is expected to grow from US$ 7.7 billion in 2022 to US$ 10.7 billion by 2030; it is projected to register a CAGR of 4.1% during 2022-2030. ![Epilepsy Market Global]( "Epilepsy Market Global")
Epilepsy is one of the most common chronic neurological disorders across the world. Associated with an abnormal electrical activity in the brain, this disorder affects over 1 million American women of childbearing age. The rising prevalence of epilepsy and increasing investments in the development of epilepsy therapies are noteworthy factors contributing to the expansion of the epilepsy market size. The administration of anti-epileptic drugs (AEDs) is usually referred to as the first-line treatment for epilepsy. Approximately 80% of the people suffering from epilepsy are from developing countries. In children as well as adults, the treatment of epilepsy is mostly based on the use of drugs (either in monotherapy or combined therapy), while the remaining treatment approaches, such as surgery, neuromodulation, and ketogenic diet, are used at a lesser frequency. However, the recall of products hinders the epilepsy market growth.
Centers for Disease Control and Prevention, the World Health Organization, and Neurological Health Charities Canada are among the primary and secondary sources referred to while preparing the epilepsy market report.
Reasons to Buy
Epilepsy is one of the most common chronic neurological disorders across the world. Associated with an abnormal electrical activity in the brain, this disorder affects over 1 million American women of childbearing age. The rising prevalence of epilepsy and increasing investments in the development of epilepsy therapies are noteworthy factors contributing to the expansion of the epilepsy market size. The administration of anti-epileptic drugs (AEDs) is usually referred to as the first-line treatment for epilepsy. Approximately 80% of the people suffering from epilepsy are from developing countries. In children as well as adults, the treatment of epilepsy is mostly based on the use of drugs (either in monotherapy or combined therapy), while the remaining treatment approaches, such as surgery, neuromodulation, and ketogenic diet, are used at a lesser frequency. However, the recall of products hinders the epilepsy market growth.
Age Group-Based Insights
Based on age group, the epilepsy market is segmented into adults and children. The adults segment held a larger epilepsy market share in 2022. It is further expected to register a higher CAGR in the market during 2022-2030. Epilepsy is more likely to develop in adults as some risk factors for this disease are more common in adults; these include diseases affecting brain function (such as Alzheimer’s disease), brain tumors, strokes, and head injuries. According to the Centers for Disease Control and Prevention (CDC), 3 million adults aged 18 or older are living with active epilepsy in the US. Nearly 1 million of these adults are aged 55 or older. As the population ages, even more older people are likely to suffer from epilepsy in the coming years. In 2021, 1.1% of US adults (~2.86 million adults) reported active epilepsy. Thus, medications and treatment strategies often prioritize adult patients, aligning with the demographic prevalence of epilepsy in this age group.End User-Based Insights
Based on distribution channel, the epilepsy market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest epilepsy market share in 2022. In addition, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022-2030. Retail pharmacy stores sell prescription drugs, over-the-counter drugs, and some fast-moving consumer goods, along with providing related services. Modern retail pharmacy chains are digitized, organized, and tech-enabled, which allows them to track medication inventories and sell 100% reliable goods. In addition, retail pharmacy chains provide value-added services for consumers opting for medical claims or insurance filings. They can also be requested to refurbish previous bills or memos. Moreover, their locations make them accessible for patients to fill their prescriptions and receive counseling from pharmacists.Centers for Disease Control and Prevention, the World Health Organization, and Neurological Health Charities Canada are among the primary and secondary sources referred to while preparing the epilepsy market report.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the epilepsy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global epilepsy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
3.2 Secondary Research
3.3 Primary Research
4. Epilepsy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2 PEST Analysis
5. Epilepsy Market - Key Market Dynamics
5.1 Epilepsy Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Epilepsy
5.2.2 Increasing Investments in Development of Epilepsy Therapies
5.3 Market Restraints
5.3.1 Recall of Products
5.4 Market Opportunities
5.4.1 Surge in Awareness Programs Conducted by Organizations
5.5 Future Trends
5.5.1 Gene Therapy as Promising Treatment Approach
5.6 Impact of Drivers and Restraints:
5.2 Market Drivers
5.2.1 Rising Prevalence of Epilepsy
5.2.2 Increasing Investments in Development of Epilepsy Therapies
5.3 Market Restraints
5.3.1 Recall of Products
5.4 Market Opportunities
5.4.1 Surge in Awareness Programs Conducted by Organizations
5.5 Future Trends
5.5.1 Gene Therapy as Promising Treatment Approach
5.6 Impact of Drivers and Restraints:
6. Epilepsy Market - Global Market Analysis
6.1 Epilepsy Market Revenue (US$ Million), 2022-2030
7. Epilepsy Market Analysis - by Type
7.1 Overview
7.2 Progressive Myoclonic Epilepsy
7.2.1 Overview
7.2.2 Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Reflex Epilepsy
7.3.1 Overview
7.3.2 Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Generalized Epilepsy
7.4.1 Overview
7.4.2 Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Other
7.5.1 Overview
7.5.2 Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Progressive Myoclonic Epilepsy
7.2.1 Overview
7.2.2 Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Reflex Epilepsy
7.3.1 Overview
7.3.2 Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Generalized Epilepsy
7.4.1 Overview
7.4.2 Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Other
7.5.1 Overview
7.5.2 Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8. Epilepsy Market Analysis - by Route of Administration
8.1 Overview
8.2 Oral
8.2.1 Overview
8.2.2 Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Parenteral
8.3.1 Overview
8.3.2 Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Oral
8.2.1 Overview
8.2.2 Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Parenteral
8.3.1 Overview
8.3.2 Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9. Epilepsy Market Analysis - by Treatment Type
9.1 Overview
9.2 First Generation Drugs
9.2.1 Overview
9.2.2 First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Second Generation Drugs
9.3.1 Overview
9.3.2 Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Third Generation Drugs
9.4.1 Overview
9.4.2 Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9.2 First Generation Drugs
9.2.1 Overview
9.2.2 First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Second Generation Drugs
9.3.1 Overview
9.3.2 Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Third Generation Drugs
9.4.1 Overview
9.4.2 Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
10. Epilepsy Market Analysis - by Age Group
10.1 Overview
10.2 Adult
10.2.1 Overview
10.2.2 Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Children
10.3.1 Overview
10.3.2 Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Adult
10.2.1 Overview
10.2.2 Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Children
10.3.1 Overview
10.3.2 Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11. Epilepsy Market Analysis - by Distribution Channel
11.1 Overview
11.2 Hospital Pharmacies
11.2.1 Overview
11.2.2 Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11.3 Retail Pharmacies
11.3.1 Overview
11.3.2 Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11.2 Hospital Pharmacies
11.2.1 Overview
11.2.2 Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11.3 Retail Pharmacies
11.3.1 Overview
11.3.2 Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12. Epilepsy Market - Geographical Analysis
12.1 North America: Epilepsy Market
12.1.1 Overview
12.1.2 North America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.2.1 North America: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.1.2.2 North America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.1.2.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.1.2.4 North America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.1.2.5 North America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.1.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.1.3.1 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.1.1 Overview
12.1.3.1.2 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.1.3 United States: Epilepsy Market Breakdown, by Type
12.1.3.1.4 United States: Epilepsy Market Breakdown, by Route of Administration
12.1.3.1.5 United States: Epilepsy Market Breakdown, by Treatment Type
12.1.3.1.6 United States: Epilepsy Market Breakdown, by Age Group
12.1.3.1.7 United States: Epilepsy Market Breakdown, by Distribution Channel
12.1.3.2 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.2.1 Overview
12.1.3.3 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.3.1 Canada: Epilepsy Market Breakdown, by Type
12.1.3.3.2 Canada: Epilepsy Market Breakdown, by Route of Administration
12.1.3.3.3 Canada: Epilepsy Market Breakdown, by Treatment Type
12.1.3.3.4 Canada: Epilepsy Market Breakdown, by Age Group
12.1.3.3.5 Canada: Epilepsy Market Breakdown, by Distribution Channel
12.1.3.4 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.4.1 Overview
12.1.3.5 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.5.1 Mexico: Epilepsy Market Breakdown, by Type
12.1.3.5.2 Mexico: Epilepsy Market Breakdown, by Route of Administration
12.1.3.5.3 Mexico: Epilepsy Market Breakdown, by Treatment Type
12.1.3.5.4 Mexico: Epilepsy Market Breakdown, by Age Group
12.1.3.5.5 Mexico: Epilepsy Market Breakdown, by Distribution Channel
12.2 Europe: Epilepsy Market
12.2.1 Overview
12.2.2 Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.2.1 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.2.2.2 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.2.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.2.2.4 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.2.2.5 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.2.3.1 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.1.1 Overview
12.2.3.2 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.2.1 United Kingdom: Epilepsy Market Breakdown, by Type
12.2.3.2.2 United Kingdom: Epilepsy Market Breakdown, by Route of Administration
12.2.3.2.3 United Kingdom: Epilepsy Market Breakdown, by Treatment Type
12.2.3.2.4 United Kingdom: Epilepsy Market Breakdown, by Age Group
12.2.3.2.5 United Kingdom: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.3 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.3.1 Overview
12.2.3.4 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.4.1 Germany: Epilepsy Market Breakdown, by Type
12.2.3.4.2 Germany: Epilepsy Market Breakdown, by Route of Administration
12.2.3.4.3 Germany: Epilepsy Market Breakdown, by Treatment Type
12.2.3.4.4 Germany: Epilepsy Market Breakdown, by Age Group
12.2.3.4.5 Germany: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.5 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.5.1 Overview
12.2.3.6 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.6.1 France: Epilepsy Market Breakdown, by Type
12.2.3.6.2 France: Epilepsy Market Breakdown, by Route of Administration
12.2.3.6.3 France: Epilepsy Market Breakdown, by Treatment Type
12.2.3.6.4 France: Epilepsy Market Breakdown, by Age Group
12.2.3.6.5 France: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.7 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.7.1 Overview
12.2.3.8 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.8.1 Spain: Epilepsy Market Breakdown, by Type
12.2.3.8.2 Spain: Epilepsy Market Breakdown, by Route of Administration
12.2.3.8.3 Spain: Epilepsy Market Breakdown, by Treatment Type
12.2.3.8.4 Spain: Epilepsy Market Breakdown, by Age Group
12.2.3.8.5 Spain: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.9 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.9.1 Overview
12.2.3.10 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.10.1 Italy: Epilepsy Market Breakdown, by Type
12.2.3.10.2 Italy: Epilepsy Market Breakdown, by Route of Administration
12.2.3.10.3 Italy: Epilepsy Market Breakdown, by Treatment Type
12.2.3.10.4 Italy: Epilepsy Market Breakdown, by Age Group
12.2.3.10.5 Italy: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.11 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.11.1 Overview
12.2.3.12 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.12.1 Rest of Europe: Epilepsy Market Breakdown, by Type
12.2.3.12.2 Rest of Europe: Epilepsy Market Breakdown, by Route of Administration
12.2.3.12.3 Rest of Europe: Epilepsy Market Breakdown, by Treatment Type
12.2.3.12.4 Rest of Europe: Epilepsy Market Breakdown, by Age Group
12.2.3.12.5 Rest of Europe: Epilepsy Market Breakdown, by Distribution Channel
12.3 Asia Pacific: Epilepsy Market
12.3.1 Overview
12.3.2 Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.2.1 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.3.2.2 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.3.2.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.3.2.4 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.3.2.5 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.3.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.3.3.1 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.1.1 Overview
12.3.3.2 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.2.1 China: Epilepsy Market Breakdown, by Type
12.3.3.2.2 China: Epilepsy Market Breakdown, by Route of Administration
12.3.3.2.3 China: Epilepsy Market Breakdown, by Treatment Type
12.3.3.2.4 China: Epilepsy Market Breakdown, by Age Group
12.3.3.2.5 China: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.3 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.3.1 Overview
12.3.3.4 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.4.1 Japan: Epilepsy Market Breakdown, by Type
12.3.3.4.2 Japan: Epilepsy Market Breakdown, by Route of Administration
12.3.3.4.3 Japan: Epilepsy Market Breakdown, by Treatment Type
12.3.3.4.4 Japan: Epilepsy Market Breakdown, by Age Group
12.3.3.4.5 Japan: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.5 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.5.1 Overview
12.3.3.6 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.6.1 India: Epilepsy Market Breakdown, by Type
12.3.3.6.2 India: Epilepsy Market Breakdown, by Route of Administration
12.3.3.6.3 India: Epilepsy Market Breakdown, by Treatment Type
12.3.3.6.4 India: Epilepsy Market Breakdown, by Age Group
12.3.3.6.5 India: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.7 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.7.1 Overview
12.3.3.8 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.8.1 Australia: Epilepsy Market Breakdown, by Type
12.3.3.8.2 Australia: Epilepsy Market Breakdown, by Route of Administration
12.3.3.8.3 Australia: Epilepsy Market Breakdown, by Treatment Type
12.3.3.8.4 Australia: Epilepsy Market Breakdown, by Age Group
12.3.3.8.5 Australia: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.9 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.9.1 Overview
12.3.3.10 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.10.1 South Korea: Epilepsy Market Breakdown, by Type
12.3.3.10.2 South Korea: Epilepsy Market Breakdown, by Route of Administration
12.3.3.10.3 South Korea: Epilepsy Market Breakdown, by Treatment Type
12.3.3.10.4 South Korea: Epilepsy Market Breakdown, by Age Group
12.3.3.10.5 South Korea: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.11 Rest of Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.11.1 Overview
12.3.3.12 Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.12.1 Rest of APAC: Epilepsy Market Breakdown, by Type
12.3.3.12.2 Rest of APAC: Epilepsy Market Breakdown, by Route of Administration
12.3.3.12.3 Rest of APAC: Epilepsy Market Breakdown, by Treatment Type
12.3.3.12.4 Rest of APAC: Epilepsy Market Breakdown, by Age Group
12.3.3.12.5 Rest of APAC: Epilepsy Market Breakdown, by Distribution Channel
12.4 Middle East & Africa Epilepsy Market
12.4.1 Overview
12.4.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.2.1 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.4.2.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.4.2.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.4.2.4 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.4.2.5 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.4.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.4.3.1 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.1.1 Overview
12.4.3.2 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.2.1 Saudi Arabia: Epilepsy Market Breakdown, by Type
12.4.3.2.2 Saudi Arabia: Epilepsy Market Breakdown, by Route of Administration
12.4.3.2.3 Saudi Arabia: Epilepsy Market Breakdown, by Treatment Type
12.4.3.2.4 Saudi Arabia: Epilepsy Market Breakdown, by Age Group
12.4.3.2.5 Saudi Arabia: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.3 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.3.1 Overview
12.4.3.4 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.4.1 South Africa: Epilepsy Market Breakdown, by Type
12.4.3.4.2 South Africa: Epilepsy Market Breakdown, by Route of Administration
12.4.3.4.3 South Africa: Epilepsy Market Breakdown, by Treatment Type
12.4.3.4.4 South Africa: Epilepsy Market Breakdown, by Age Group
12.4.3.4.5 South Africa: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.5 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.5.1 Overview
12.4.3.6 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.6.1 United Arab Emirates: Epilepsy Market Breakdown, by Type
12.4.3.6.2 United Arab Emirates: Epilepsy Market Breakdown, by Route of Administration
12.4.3.6.3 United Arab Emirates: Epilepsy Market Breakdown, by Treatment Type
12.4.3.6.4 United Arab Emirates: Epilepsy Market Breakdown, by Age Group
12.4.3.6.5 United Arab Emirates: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.7 Rest of Middle East & Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.7.1 Overview
12.4.3.8 Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.8.1 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Type
12.4.3.8.2 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Route of Administration
12.4.3.8.3 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Treatment Type
12.4.3.8.4 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Age Group
12.4.3.8.5 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Distribution Channel
12.5 South & Central America: Epilepsy Market
12.5.1 Overview
12.5.2 South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.2.1 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.5.2.2 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.5.2.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.5.2.4 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.5.2.5 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.5.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.5.3.1 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.1.1 Overview
12.5.3.2 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.2.1 Brazil: Epilepsy Market Breakdown, by Type
12.5.3.2.2 Brazil: Epilepsy Market Breakdown, by Route of Administration
12.5.3.2.3 Brazil: Epilepsy Market Breakdown, by Treatment Type
12.5.3.2.4 Brazil: Epilepsy Market Breakdown, by Age Group
12.5.3.2.5 Brazil: Epilepsy Market Breakdown, by Distribution Channel
12.5.3.3 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.3.1 Overview
12.5.3.4 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.4.1 Argentina: Epilepsy Market Breakdown, by Type
12.5.3.4.2 Argentina: Epilepsy Market Breakdown, by Route of Administration
12.5.3.4.3 Argentina: Epilepsy Market Breakdown, by Treatment Type
12.5.3.4.4 Argentina: Epilepsy Market Breakdown, by Age Group
12.5.3.4.5 Argentina: Epilepsy Market Breakdown, by Distribution Channel
12.5.3.5 Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.5.1 Overview
12.5.3.6 Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.6.1 Rest of South and Central America: Epilepsy Market Breakdown, by Type
12.5.3.6.2 Rest of South and Central America: Epilepsy Market Breakdown, by Route of Administration
12.5.3.6.3 Rest of South and Central America: Epilepsy Market Breakdown, by Treatment Type
12.5.3.6.4 Rest of South and Central America: Epilepsy Market Breakdown, by Age Group
12.5.3.6.5 Rest of South and Central America: Epilepsy Market Breakdown, by Distribution Channel
12.1.1 Overview
12.1.2 North America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.2.1 North America: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.1.2.2 North America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.1.2.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.1.2.4 North America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.1.2.5 North America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.1.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.1.3.1 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.1.1 Overview
12.1.3.1.2 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.1.3 United States: Epilepsy Market Breakdown, by Type
12.1.3.1.4 United States: Epilepsy Market Breakdown, by Route of Administration
12.1.3.1.5 United States: Epilepsy Market Breakdown, by Treatment Type
12.1.3.1.6 United States: Epilepsy Market Breakdown, by Age Group
12.1.3.1.7 United States: Epilepsy Market Breakdown, by Distribution Channel
12.1.3.2 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.2.1 Overview
12.1.3.3 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.3.1 Canada: Epilepsy Market Breakdown, by Type
12.1.3.3.2 Canada: Epilepsy Market Breakdown, by Route of Administration
12.1.3.3.3 Canada: Epilepsy Market Breakdown, by Treatment Type
12.1.3.3.4 Canada: Epilepsy Market Breakdown, by Age Group
12.1.3.3.5 Canada: Epilepsy Market Breakdown, by Distribution Channel
12.1.3.4 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.4.1 Overview
12.1.3.5 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.1.3.5.1 Mexico: Epilepsy Market Breakdown, by Type
12.1.3.5.2 Mexico: Epilepsy Market Breakdown, by Route of Administration
12.1.3.5.3 Mexico: Epilepsy Market Breakdown, by Treatment Type
12.1.3.5.4 Mexico: Epilepsy Market Breakdown, by Age Group
12.1.3.5.5 Mexico: Epilepsy Market Breakdown, by Distribution Channel
12.2 Europe: Epilepsy Market
12.2.1 Overview
12.2.2 Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.2.1 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.2.2.2 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.2.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.2.2.4 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.2.2.5 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.2.3.1 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.1.1 Overview
12.2.3.2 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.2.1 United Kingdom: Epilepsy Market Breakdown, by Type
12.2.3.2.2 United Kingdom: Epilepsy Market Breakdown, by Route of Administration
12.2.3.2.3 United Kingdom: Epilepsy Market Breakdown, by Treatment Type
12.2.3.2.4 United Kingdom: Epilepsy Market Breakdown, by Age Group
12.2.3.2.5 United Kingdom: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.3 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.3.1 Overview
12.2.3.4 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.4.1 Germany: Epilepsy Market Breakdown, by Type
12.2.3.4.2 Germany: Epilepsy Market Breakdown, by Route of Administration
12.2.3.4.3 Germany: Epilepsy Market Breakdown, by Treatment Type
12.2.3.4.4 Germany: Epilepsy Market Breakdown, by Age Group
12.2.3.4.5 Germany: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.5 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.5.1 Overview
12.2.3.6 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.6.1 France: Epilepsy Market Breakdown, by Type
12.2.3.6.2 France: Epilepsy Market Breakdown, by Route of Administration
12.2.3.6.3 France: Epilepsy Market Breakdown, by Treatment Type
12.2.3.6.4 France: Epilepsy Market Breakdown, by Age Group
12.2.3.6.5 France: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.7 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.7.1 Overview
12.2.3.8 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.8.1 Spain: Epilepsy Market Breakdown, by Type
12.2.3.8.2 Spain: Epilepsy Market Breakdown, by Route of Administration
12.2.3.8.3 Spain: Epilepsy Market Breakdown, by Treatment Type
12.2.3.8.4 Spain: Epilepsy Market Breakdown, by Age Group
12.2.3.8.5 Spain: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.9 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.9.1 Overview
12.2.3.10 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.10.1 Italy: Epilepsy Market Breakdown, by Type
12.2.3.10.2 Italy: Epilepsy Market Breakdown, by Route of Administration
12.2.3.10.3 Italy: Epilepsy Market Breakdown, by Treatment Type
12.2.3.10.4 Italy: Epilepsy Market Breakdown, by Age Group
12.2.3.10.5 Italy: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.11 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.11.1 Overview
12.2.3.12 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.2.3.12.1 Rest of Europe: Epilepsy Market Breakdown, by Type
12.2.3.12.2 Rest of Europe: Epilepsy Market Breakdown, by Route of Administration
12.2.3.12.3 Rest of Europe: Epilepsy Market Breakdown, by Treatment Type
12.2.3.12.4 Rest of Europe: Epilepsy Market Breakdown, by Age Group
12.2.3.12.5 Rest of Europe: Epilepsy Market Breakdown, by Distribution Channel
12.3 Asia Pacific: Epilepsy Market
12.3.1 Overview
12.3.2 Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.2.1 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.3.2.2 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.3.2.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.3.2.4 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.3.2.5 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.3.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.3.3.1 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.1.1 Overview
12.3.3.2 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.2.1 China: Epilepsy Market Breakdown, by Type
12.3.3.2.2 China: Epilepsy Market Breakdown, by Route of Administration
12.3.3.2.3 China: Epilepsy Market Breakdown, by Treatment Type
12.3.3.2.4 China: Epilepsy Market Breakdown, by Age Group
12.3.3.2.5 China: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.3 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.3.1 Overview
12.3.3.4 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.4.1 Japan: Epilepsy Market Breakdown, by Type
12.3.3.4.2 Japan: Epilepsy Market Breakdown, by Route of Administration
12.3.3.4.3 Japan: Epilepsy Market Breakdown, by Treatment Type
12.3.3.4.4 Japan: Epilepsy Market Breakdown, by Age Group
12.3.3.4.5 Japan: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.5 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.5.1 Overview
12.3.3.6 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.6.1 India: Epilepsy Market Breakdown, by Type
12.3.3.6.2 India: Epilepsy Market Breakdown, by Route of Administration
12.3.3.6.3 India: Epilepsy Market Breakdown, by Treatment Type
12.3.3.6.4 India: Epilepsy Market Breakdown, by Age Group
12.3.3.6.5 India: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.7 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.7.1 Overview
12.3.3.8 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.8.1 Australia: Epilepsy Market Breakdown, by Type
12.3.3.8.2 Australia: Epilepsy Market Breakdown, by Route of Administration
12.3.3.8.3 Australia: Epilepsy Market Breakdown, by Treatment Type
12.3.3.8.4 Australia: Epilepsy Market Breakdown, by Age Group
12.3.3.8.5 Australia: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.9 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.9.1 Overview
12.3.3.10 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.10.1 South Korea: Epilepsy Market Breakdown, by Type
12.3.3.10.2 South Korea: Epilepsy Market Breakdown, by Route of Administration
12.3.3.10.3 South Korea: Epilepsy Market Breakdown, by Treatment Type
12.3.3.10.4 South Korea: Epilepsy Market Breakdown, by Age Group
12.3.3.10.5 South Korea: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.11 Rest of Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.11.1 Overview
12.3.3.12 Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.3.3.12.1 Rest of APAC: Epilepsy Market Breakdown, by Type
12.3.3.12.2 Rest of APAC: Epilepsy Market Breakdown, by Route of Administration
12.3.3.12.3 Rest of APAC: Epilepsy Market Breakdown, by Treatment Type
12.3.3.12.4 Rest of APAC: Epilepsy Market Breakdown, by Age Group
12.3.3.12.5 Rest of APAC: Epilepsy Market Breakdown, by Distribution Channel
12.4 Middle East & Africa Epilepsy Market
12.4.1 Overview
12.4.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.2.1 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.4.2.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.4.2.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.4.2.4 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.4.2.5 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.4.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.4.3.1 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.1.1 Overview
12.4.3.2 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.2.1 Saudi Arabia: Epilepsy Market Breakdown, by Type
12.4.3.2.2 Saudi Arabia: Epilepsy Market Breakdown, by Route of Administration
12.4.3.2.3 Saudi Arabia: Epilepsy Market Breakdown, by Treatment Type
12.4.3.2.4 Saudi Arabia: Epilepsy Market Breakdown, by Age Group
12.4.3.2.5 Saudi Arabia: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.3 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.3.1 Overview
12.4.3.4 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.4.1 South Africa: Epilepsy Market Breakdown, by Type
12.4.3.4.2 South Africa: Epilepsy Market Breakdown, by Route of Administration
12.4.3.4.3 South Africa: Epilepsy Market Breakdown, by Treatment Type
12.4.3.4.4 South Africa: Epilepsy Market Breakdown, by Age Group
12.4.3.4.5 South Africa: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.5 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.5.1 Overview
12.4.3.6 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.6.1 United Arab Emirates: Epilepsy Market Breakdown, by Type
12.4.3.6.2 United Arab Emirates: Epilepsy Market Breakdown, by Route of Administration
12.4.3.6.3 United Arab Emirates: Epilepsy Market Breakdown, by Treatment Type
12.4.3.6.4 United Arab Emirates: Epilepsy Market Breakdown, by Age Group
12.4.3.6.5 United Arab Emirates: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.7 Rest of Middle East & Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.7.1 Overview
12.4.3.8 Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.4.3.8.1 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Type
12.4.3.8.2 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Route of Administration
12.4.3.8.3 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Treatment Type
12.4.3.8.4 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Age Group
12.4.3.8.5 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Distribution Channel
12.5 South & Central America: Epilepsy Market
12.5.1 Overview
12.5.2 South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.2.1 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Type
12.5.2.2 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
12.5.2.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
12.5.2.4 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
12.5.2.5 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
12.5.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Country
12.5.3.1 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.1.1 Overview
12.5.3.2 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.2.1 Brazil: Epilepsy Market Breakdown, by Type
12.5.3.2.2 Brazil: Epilepsy Market Breakdown, by Route of Administration
12.5.3.2.3 Brazil: Epilepsy Market Breakdown, by Treatment Type
12.5.3.2.4 Brazil: Epilepsy Market Breakdown, by Age Group
12.5.3.2.5 Brazil: Epilepsy Market Breakdown, by Distribution Channel
12.5.3.3 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.3.1 Overview
12.5.3.4 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.4.1 Argentina: Epilepsy Market Breakdown, by Type
12.5.3.4.2 Argentina: Epilepsy Market Breakdown, by Route of Administration
12.5.3.4.3 Argentina: Epilepsy Market Breakdown, by Treatment Type
12.5.3.4.4 Argentina: Epilepsy Market Breakdown, by Age Group
12.5.3.4.5 Argentina: Epilepsy Market Breakdown, by Distribution Channel
12.5.3.5 Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.5.1 Overview
12.5.3.6 Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
12.5.3.6.1 Rest of South and Central America: Epilepsy Market Breakdown, by Type
12.5.3.6.2 Rest of South and Central America: Epilepsy Market Breakdown, by Route of Administration
12.5.3.6.3 Rest of South and Central America: Epilepsy Market Breakdown, by Treatment Type
12.5.3.6.4 Rest of South and Central America: Epilepsy Market Breakdown, by Age Group
12.5.3.6.5 Rest of South and Central America: Epilepsy Market Breakdown, by Distribution Channel
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Epilepsy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
13.2 Growth Strategies in Epilepsy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Pfizer Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Eisai Co Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 UCB SA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 CombiGene AB
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 LivaNova Plc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Medtronic Plc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 GSK Plc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 H. Lundbeck AS
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Pfizer Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Eisai Co Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 UCB SA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 CombiGene AB
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 LivaNova Plc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Medtronic Plc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 GSK Plc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 H. Lundbeck AS
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
List of Tables
Table 1. Epilepsy Market Segmentation
Table 2. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 3. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 4. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 5. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 6. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 7. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 8. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 9. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 10. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 11. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 12. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 13. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 14. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 15. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 16. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 17. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 18. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 19. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 20. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 21. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 22. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 23. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 24. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 25. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 26. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 27. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 28. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 29. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 30. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 31. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 32. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 33. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 34. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 35. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 36. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 37. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 38. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 39. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 40. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 41. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 42. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 43. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 44. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 45. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 46. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 47. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 48. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 49. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 50. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 51. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 52. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 53. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 54. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 55. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 56. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 57. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 58. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 59. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 60. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 61. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 62. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 63. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 64. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 65. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 66. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 67. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 68. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 69. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 70. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 71. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 72. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 73. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 74. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 75. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 76. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 77. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 78. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 79. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 80. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 81. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 82. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 83. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 84. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 85. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 86. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 87. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 88. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 89. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 90. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 91. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 92. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 93. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 94. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 95. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 96. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 97. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 98. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 99. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 100. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 101. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 102. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 103. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 104. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 105. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 106. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 107. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 108. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 109. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 110. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 111. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 112. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 113. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 114. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 115. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 116. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 117. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 118. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 119. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 120. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 121. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 122. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 123. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 124. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 125. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 126. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 127. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 128. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 129. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 130. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 131. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 132. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 133. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 134. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 135. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 136. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 137. Recent Organic Growth Strategies in Epilepsy Market
Table 138. Recent Inorganic Growth Strategies in the Epilepsy Market
Table 2. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 3. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 4. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 5. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 6. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 7. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 8. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 9. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 10. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 11. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 12. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 13. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 14. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 15. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 16. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 17. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 18. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 19. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 20. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 21. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 22. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 23. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 24. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 25. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 26. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 27. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 28. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 29. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 30. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 31. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 32. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 33. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 34. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 35. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 36. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 37. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 38. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 39. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 40. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 41. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 42. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 43. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 44. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 45. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 46. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 47. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 48. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 49. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 50. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 51. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 52. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 53. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 54. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 55. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 56. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 57. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 58. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 59. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 60. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 61. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 62. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 63. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 64. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 65. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 66. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 67. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 68. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 69. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 70. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 71. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 72. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 73. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 74. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 75. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 76. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 77. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 78. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 79. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 80. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 81. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 82. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 83. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 84. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 85. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 86. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 87. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 88. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 89. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 90. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 91. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 92. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 93. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 94. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 95. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 96. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 97. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 98. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 99. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 100. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 101. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 102. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 103. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 104. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 105. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 106. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 107. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 108. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 109. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 110. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 111. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 112. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 113. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 114. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 115. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 116. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 117. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 118. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 119. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 120. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 121. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 122. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 123. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 124. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 125. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 126. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 127. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 128. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 129. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 130. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 131. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 132. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 133. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 134. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 135. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 136. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 137. Recent Organic Growth Strategies in Epilepsy Market
Table 138. Recent Inorganic Growth Strategies in the Epilepsy Market
List of Figures
Figure 1. Epilepsy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Epilepsy Market Revenue (US$ Million), 2022-2030
Figure 5. Epilepsy Market Revenue, Geography (US$ Mn), 2022 - 2030
Figure 6. Epilepsy Market Share (%) - by Type (2022 and 2030)
Figure 7. Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Epilepsy Market Share (%) - by Route of Administration (2022 and 2030)
Figure 12. Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy Market Share (%) - by Treatment Type (2022 and 2030)
Figure 16. First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Epilepsy Market Share (%) - by Age Group (2022 and 2030)
Figure 20. Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Epilepsy Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 23. Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. North America: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 27. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. North America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 29. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Europe: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 33. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Europe: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 35. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 41. Asia Pacific: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 42. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 43. Asia Pacific: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 44. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 45. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 46. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 47. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 48. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 49. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 50. Middle East & Africa: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 51. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 52. Middle East and Africa: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 54. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 55. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 56. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 57. South & Central America: Epilepsy Market, By Key Country - Revenue (2022) (US$ Million)
Figure 58. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 59. South and Central America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 60. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 61. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 62. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 63. Growth Strategies in Epilepsy Market
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Epilepsy Market Revenue (US$ Million), 2022-2030
Figure 5. Epilepsy Market Revenue, Geography (US$ Mn), 2022 - 2030
Figure 6. Epilepsy Market Share (%) - by Type (2022 and 2030)
Figure 7. Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Epilepsy Market Share (%) - by Route of Administration (2022 and 2030)
Figure 12. Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy Market Share (%) - by Treatment Type (2022 and 2030)
Figure 16. First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Epilepsy Market Share (%) - by Age Group (2022 and 2030)
Figure 20. Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Epilepsy Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 23. Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. North America: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 27. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. North America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 29. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Europe: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 33. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Europe: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 35. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 41. Asia Pacific: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 42. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 43. Asia Pacific: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 44. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 45. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 46. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 47. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 48. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 49. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 50. Middle East & Africa: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 51. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 52. Middle East and Africa: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 54. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 55. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 56. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 57. South & Central America: Epilepsy Market, By Key Country - Revenue (2022) (US$ Million)
Figure 58. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 59. South and Central America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 60. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 61. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 62. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 63. Growth Strategies in Epilepsy Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Pfizer Inc
- Eisai Co Ltd
- UCB SA
- CombiGene AB
- Livanova PLC
- Novartis AG
- Medtronic PLC
- GSK PLC
- H. Lundbeck AS.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 230 |
| Published | February 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value in 2022 | 7.7 Billion |
| Forecasted Market Value by 2030 | 10.7 Billion |
| Compound Annual Growth Rate | 4.1% |
| Regions Covered | Global |
